Monday, October 22, 2007 - 18:43

Innate Pharma SA anounces that it has received approval from the French authorities to start an exploratory Phase II clinical trial in chronic myeloid leukemia ("CML") with IPH 1101.

AttachmentSize
PR in english86.69 KB
CP en fran├žais90.96 KB